What We Do
Acidophil is an innovation company that uses synthetic biology and/or synthetic chemistry to apply the lessons of evolution to the discovery and development of novel bioactive compounds and related production processes for a variety of market sectors. Intellectual property is invented and exemplified using Acidophil’s network of contract research organizations and academic collaborators alongside a small research laboratory.
Acidophil focuses its innovation on business opportunities presented by unmet market needs. These opportunities are identified through a combination of secondary research, analyzing existing markets to identify gaps, and primary research through extensive discussions with end users of a technology, for example, clinicians and corporate partners.
Acidophil works with strategic partners to define the specific market needs on which to focus and to fund programs through combinations of strategic funding, internal Acidophil funding, angel investors, and institutional venture capital.